Follow-up data from CARTITUDE-4 show at least 80 percent of as-treated standard-risk patients remained progression and treatment-free following a single ...

TIBSOVO is a targeted therapy that works against an abnormal protein created by a mutation in the IDH1 gene. This abnormal ...

Triple-class exposed patients with three prior lines of therapy in CARTITUDE-1 and CARTITUDE-4 achieved a median PFS of 50.4 months after a ...

Willis-Ekbom disease—more commonly known as restless legs syndrome—is a condition that causes an irresistible urge to move the legs. At its best it's inconvenient, and at its worst it can cause ...

By Tarun Sai Lomte A 15-year national health analysis reveals that people with restless legs syndrome are more likely to ...

Researchers at Örebro University have, for the first time, shown directly in the human intestine that butyric acid can ...

This case report describes a woman in her late 50s with reversible pulmonary hypertension (PH) due to scurvy, a rare vitamin ...

Researchers at the Jane Addams College of Social Work at the University of Illinois Chicago have found that cannabinoid hyperemesis syndrome, a vomiting condition tied to chronic cannabis use, rose ...

Briton Tom Aspinall said he has been diagnosed with Brown’s syndrome in both eyes and is not cleared to fight after an ...

Rebecca Adlington established herself as one of Britain’s greatest-ever athletes – then she lost her energy.  In 2008, a ...

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that eight abstracts, including four that are late-breaking, will be presented on Epidiolex® (cannabidiol) at the American Epilepsy Society (AES ...